Duty Stuart — SEC Form 4 filings
SEC reporting owner CIK 1970274. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-25.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-09 to 2026-06-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | Director | 4 | — | — | 4 |
| EyePoint, Inc. (EYPT) | Director | 3 | — | — | 3 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | Director | 2 | — | — | 2 |
| Foghorn Therapeutics Inc. (FHTX) | Director | 2 | — | — | 2 |
Form 4 filings — Duty Stuart
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-25 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 28,000 (derivative) @ $4.08 | EDGAR |
| 2026-06-12 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 77,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | EyePoint, Inc. (EYPT) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-10 | 4 | ACHIEVE LIFE SCIENCES, INC. (ACHV) | Grant/award (A): 31,500 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | Foghorn Therapeutics Inc. (FHTX) | Grant/award (A): 50,000 (derivative) @ $4.16 | EDGAR |
| 2025-01-07 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-08-29 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-07-17 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | ACHIEVE LIFE SCIENCES, INC. (ACHV) | Grant/award (A): 31,500 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Grant/award (A): 25,014 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1970274 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →